New research suggests enhancing the brain’s own immune cells could help clear plaques associated with Alzheimer’s disease.

But he implied that only misguided contrarians could dispute that lecanemab established the amyloid hypothesis as fact, and that such drugs would illuminate the path to solve the Alzheimer’s puzzle.

“Matthew really opened up a new form of epigenetic inheritance,” says Dr. Brent Derry, Eroglu’s supervisor. “He found that amyloids can be inherited, marking a significant discovery in protein-based ...

Chicago area scientists have identified the genes that drive the process of Alzheimer’s disease and are working to make the drug Lecanemab even better by identifying which genes are active ...

Scientists have long been racking their brains for ways to treat Alzheimer’s disease, the most common type of dementia.

For more than three decades, scientists have been racing to stop Alzheimer's disease by removing amyloid beta plaques—sticky ...

Northwestern researchers made progress on new biochemical possibilities this week, in both the human brain and everyday ...